Why the study?
Does risk-stratified dalteparin prophylaxis prevent venous thromboembolism in pregnant women at increased risk?
Population
810 pregnant women at increased risk of venous thromboembolism due to a history of VTE, thrombophilia, or…
Design
Cohort
Follow-up
Up to 6 weeks postpartum
Authors
Loading...
Low VTE incidence with risk-stratified dalteparin; hypothesis-generating and requires randomized trials before practice change.
Does risk-stratified dalteparin prophylaxis prevent venous thromboembolism in pregnant women at increased risk?
Risk-stratified dalteparin prophylaxis in pregnant women at increased risk of VTE is associated with a low incidence of symptomatic VTE and few clinically important adverse events.
Dudenhausen et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: